Related Experiment Videos
[Progress in the treatment of chronic lymphocytic leukemia]
Acta Haematologica Polonica
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
Acta haematologica Polonica·1995
[Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
Acta haematologica Polonica·1995
[Effectiveness of interferon alfa in different stages of thrombocythemia (preliminary report)].
Acta haematologica Polonica·1991
The results of treatment of selected patients with ANLL with low-dose Ara-C.
Folia haematologica (Leipzig, Germany : 1928)·1989
ALG/ATG treatment--a useful alternative for BMT in selected aplastic anaemia patients.
Folia haematologica (Leipzig, Germany : 1928)·1989
[Results of the treatment of patients with advanced Hodgkin's disease by the ABDiC and/or BVCPP protocols].
Acta haematologica Polonica·1989
[Risk of transmission of blood-derived pathogens by transfusion in Poland].
Acta haematologica Polonica·2020
[Emerging infectious diseases in the context of blood safety].
Acta haematologica Polonica·2020
Quo Vadis medycyno regeneracyjna?: Quo Vadis Regenerative Medicine?
Acta haematologica Polonica·2013
[RHnull syndrome--diagnostic and therapeutic problems].
Acta haematologica Polonica·1996
[Unclassified chronic myeloproliferative Ph(-); i(17q); +8 syndrome with mixed myelo-megakaryoblastic crisis--case report].
Acta haematologica Polonica·1996
Acute myelofibrosis in children: report on two cases.
Acta haematologica Polonica·1996
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026